A fatal case of simultaneous, very late thrombosis involving three drug-eluting stents in three coronary arteries

Korean Circulation Journal

Volumn 38, Issue 10, 2008, Pages 564-569

  Ahn, Yong Soo ^a   Cho, Jang Hyun ^a   Kim, Dong Han ^a   Hwang, Young June ^a   Jung, Hong Myong ^a   Choi, Min Seok ^a   Kim, Joon Young ^a   Jeong, Myung Ho ^b  

^a Saint Carollo Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Platelets; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; TENECTEPLASE; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOGENIC SHOCK; CASE REPORT; COMA; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART INFARCTION; HEART PACING; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESUSCITATION; ST SEGMENT ELEVATION; STENT THROMBOSIS; T WAVE INVERSION; THORAX PAIN; THROMBOSIS; THROMBUS ASPIRATION;

EID: 57049111606     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.10.564     Document Type: Article

References (19)

1. Grube E, Silber S, Hauptmann KE, et al. Two year-plus follow up of paclitaxel-eluting stent in de novo coronary narrowing (TAXUS I). Am J Cardiol 2005;96:79-82.
2. Degertekin M, Serruys PW, Foley DP, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002;106:1610-3.
3. Fajadet J, Wijns W, Laarman GJ, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphoryl-choline-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806.
4. Moreno R, Fernandez C, Hermandez R, et al. Drug-eluting stent thrombosis: result from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-9.
5. Schampaert E, Moses JW, Schofer J, et al. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thrombosis. Am J Cardiol 2006;98:36-41.
6. Iakovou I, Schmodt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stent. JAMA 2005;293:2126-30.
7. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78.
8. Park SH, Hong GR, Seo HS, Tahk SJ. Stent thrombosis after successful drug-eluting stent implantation. Korean Circ J 2005; 35:163-71.
9. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
10. Moon JY, Jeong MH, Jun CH, et al. The frequency, treatment and clinical outcomes of stent thrombosis after use of TAXUS stent. Korean Circ J 2007;37:641-6.
11. Wernick MH, Jeremias A, Carrozza JP. Drug-eluting stents and stent thrombosis: a cause for concern? Coron Artery Dis 2006; 17:661-5.
12. Park DW, Park SW. Stent thrombosis in the era of the drug-eluting stent. Korean Circ J 2005;35:791-4.
13. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-53.
14. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiograhpic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-92.
15. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
16. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-7.
17. Goel PK, Gill GS. Angioplasty for the late stent thrombosis, the new technical challenge: a single centre experience. Int J Cardiol 2008;123:335-7.
18. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis. J Intern Med 2005; 257:399-414.
19. Leibowitz D, Cohen M, Planer D, et al. Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stenting. Am J Cardiol 2006;97:1188-91.